REVERSIBILITY OF ANDROGEN DEPRIVATION THERAPY IN PATIENTS WITH PROSTATE CANCER-Reference-Cited by-同舟云学术

REVERSIBILITY OF ANDROGEN DEPRIVATION THERAPY IN PATIENTS WITH PROSTATE CANCER

Published:2005-03 Issue:3 Volume:173 Page:784-789
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

FRIDMANS ALON¹,CHERTIN BORIS¹,KOULIKOV DMITRY¹,LINDENBERG TZINA¹,GELBER HADASSA¹,LEITER CHAVIE¹,FARKAS AMICUR¹,SPITZ IRVING M.¹

Affiliation:

1. From the Department of Urology (AF, BC, DK, AF) and Institute of Hormone Research (TL, HG, CL, IMS), Shaare Zedek Medical Center, Jerusalem, affiliated with the Faculty of Health Sciences Ben-Gurion University of the Negev, Israel

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. Cancer statistics, 2000

2. AUTHOR INDEX

3. A Phase 3, Multicenter, Open Label, Randomized Study Of Abarelix Versus Leuprolide Plus Daily Antiandrogen In Men With Prostate Cancer

4. Molecular and Cellular Bases of Gonadotropin-Releasing Hormone Action in the Pituitary and Central Nervous System

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial;Radiotherapy and Oncology;2021-07

2. A Nomogram for Testosterone Recovery After Combined Androgen Deprivation and Radiation Therapy for Prostate Cancer;International Journal of Radiation Oncology*Biology*Physics;2019-03

3. Investigations on the dose–response relationship of combined exposure to low doses of three anti-androgens in Wistar rats;Archives of Toxicology;2017-09-06

4. Tailor-Made Hydrogels for Tumor Delivery;Drug Delivery in Oncology;2011-12-16

5. Long-term efficacy and tolerability of once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancer;BJU International;2011-08-18